NCT05489055

Brief Summary

Extrinsic prewarming of iodinated CT contrast media (CM) to body temperature reduces viscosity and injection pressures. However, guideline recommendations on the necessity to prewarm iodinated CM are conflicting. And studies examining the effect of extrinsic warming CM for coronary CTA(CCTA) on clinical adverse events and image quality are lack. Enrolled patients of chest pain or coronary artery disease screening were eligible for this a double-blinded, randomized noninferiority trial, and equally allocated into two group randomly: BBT-CM (basic body temperature) group received 37°C CM; RT-CM (room temperature) group received \~23°C CM. A state-of-the-art individualized CM (iopamidol at 370 mg I/mL) injection protocol was used, based on body weight.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

August 5, 2022

Status Verified

August 1, 2022

Enrollment Period

11 months

First QC Date

August 1, 2022

Last Update Submit

August 3, 2022

Conditions

Keywords

Computed Tomography AngiographyLow-osmolality contrast mediaImage qualityClinical adverse event

Outcome Measures

Primary Outcomes (1)

  • Vessel Attenuation

    Mean attenuation in Hounsfield Units (HU) is based on coronary bifurcation, preferably right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex coronary artery (LCX)). Absolute difference in mean attenuation of coronary vessels between groups was calculated with a two-sided 95% confidence interval of the difference.

    Expected within one month after the coronary CTA is performed

Secondary Outcomes (11)

  • Allergic or allergiclike reaction

    30 minutes after coronary CTA

  • Extravasations

    Expected during the coronary CTA scan.

  • Objective image quality - Signal-to-noise ratio(SNR)

    Within one month after the CT is performed

  • Objective image quality -Contrast-to-noise ratio(CNR)

    Within one month after the CT is performed

  • CT Dose Index (CTDI)vol

    Expected during the coronary CTA is performed

  • +6 more secondary outcomes

Study Arms (2)

BBT-CM (basic body temperature) group

EXPERIMENTAL

BBT-CM (basic body temperature) group received contrast media warmed to body temperature (37°C\[99°F\]) before coronary CTA.

Drug: Iopamidol

RT-CM (room temperature) group

ACTIVE COMPARATOR

RT-CM (room temperature) group received contrast media at room temperature (\~23°C \[\~73°F\]) before coronary CTA.

Drug: Iopamidol

Interventions

A contrast bolus of iopamidol-370 (370 mg I/ml) (iopamidol injection; Consun Pharmaceutical, China) was injected at a flow rate of 4.5-6 mL/s through an 18-20-gauge intravenous antecubital catheter by using a power injector (Ulrich, Germany). The total dose of iopamidol-370 was approximately 0.9 ml /kg body weight.

BBT-CM (basic body temperature) groupRT-CM (room temperature) group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Coronary symptomatic patients (i.e., chest pain).
  • Patients for Coronary artery disease screening

You may not qualify if:

  • Hemodynamic instability
  • Renal insufficiency (estimated glomerular filtration rate \<30 mL/min per 1.73 m2)
  • Prior adverse reactions to iodinated CM
  • Age younger than 18 years
  • Inability to place an 18-gauge needle.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chongqing Emergency Mediacl Centre

Chongqing, Chonqing, 400042, China

RECRUITING

Related Publications (3)

  • Basharat NF, Ranganathan K, Kang PT, Gridley DG, Roh AT. Effect of Extrinsic Warming of Low-Osmolality CT Contrast Media (Iohexol 350) on Extravasations and Patient Reaction Rates: A Retrospective Study. AJR Am J Roentgenol. 2022 Jan;218(1):174-179. doi: 10.2214/AJR.21.26256. Epub 2021 Jul 28.

    PMID: 34319163BACKGROUND
  • Martens B, Wildberger JE, Van Kuijk SMJ, De Vos-Geelen J, Jeukens CRLPN, Mihl C. Influence of Contrast Material Temperature on Patient Comfort and Image Quality in Computed Tomography of the Abdomen: A Randomized Controlled Trial. Invest Radiol. 2022 Feb 1;57(2):85-89. doi: 10.1097/RLI.0000000000000807.

  • Peng C, Liu Y, Zhang H, Xu G, He C, Jian D, Liu H, Li C, Zeng P, Wu H. Effects of extrinsically warmed contrast media on image quality and clinical adverse events in patients undergoing coronary computed tomography angiography: a randomized controlled trial. Quant Imaging Med Surg. 2026 Jan 1;16(1):13. doi: 10.21037/qims-2025-121. Epub 2025 Dec 31.

MeSH Terms

Interventions

Iopamidol

Intervention Hierarchy (Ancestors)

Triiodobenzoic AcidsIodobenzoatesBenzoatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 1, 2022

First Posted

August 5, 2022

Study Start

February 1, 2022

Primary Completion

January 1, 2023

Study Completion

February 28, 2023

Last Updated

August 5, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations